IGC Pharma, Inc. (IGC) stock analysis and AI prediction
The company facts of IGC Pharma, Inc., with its price and AI prediction for the next 10 market days in SharePreds.
Keep looking in SharePreds
You have looked at today's stocks on this website. SharePreds shows every stock's likelihood of rising, its chart and how its earlier predictions ended, with alerts on the ones you follow.
See all five apps
About IGC Pharma, Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.
- Sector
- Healthcare
- Exchange
- AMEX
- Market value
- $21.5 million
- Size
- Micro cap
- Employees
- 70
- Headquarters
- POTOMAC, MD
- Listed since
- April 13, 2006
- Website
- igcinc.us
More Healthcare stocks
Other micro cap stocks
Keep going
IGC questions
What is the AI prediction for IGC stock?
Each market day our model rates IGC Pharma, Inc. (IGC) Bullish, Neutral or Bearish for the next 10 market days. Predictions are indicative: they rest on price and volume data, and they can be wrong.
How often is the IGC prediction updated?
Each market day, Monday to Friday, except market holidays. The date of the prediction is shown beside it.
What do Bullish, Neutral and Bearish mean?
Bullish means the model sees a rise as likely over the next 10 market days, Bearish a fall, and Neutral no clear direction.
Where can I see the exact likelihood for IGC?
In the SharePreds app for iPhone and Android, with the stock's chart, alerts on it and how its earlier predictions ended.
Where can I see IGC options?
The IGC options page opens its calls and puts, with price, volume, implied volatility and the Greeks.